AIDS 2024, the 25th International AIDS Conference

Sessions & Speakers

1. Saturday 07/20

   Pre-Conference Event Session | 08:00 – 9:00 CEST | Conference Venue

   Welcome to the Era of PrEP Choice

   USAID, Unitaid, the Bill & Melinda Gates Foundation, and the World Health Organization with organizational support from the MOSAIC project are hosting a pre-conference event that will explore a new era of pre-exposure prophylaxis (PrEP) choice and will include dynamic sessions on the PrEP product introduction landscape, the transformative potential of PrEP choice, key programmatic considerations, and early learnings from efforts to deliver PrEP choice around the world.

    

   The Council’s Leonard Solai will participate in the first session’s panel, “The PrEP Introduction Landscape.”

    

   More information about the pre-conference event, including registration, is available here.

    

2. Tuesday 07/23

   E-Poster | 10:00 CEST | Online

   Perspectives of cisgender women, transgender men, and healthcare providers on an HIV risk self-assessment digital chatbot (Abstract)

   S. Mathur*, W. Tun, A. Eromhonsele, Z. Vallarino, O. Ononye, C. Savel, M. Akoro, E. Oche, A. Adedimeji, E. Shoyemi

    

   Poster Exhibition | 12:00–13:00 CEST | Exhibition Hall

   (Posters are on display all day, but presenters stand by their posters during this time)

    

   TUPEC192

   Acceptability of a dual prevention pill versus PrEP and oral contraceptives taken separately: women’s baseline preferences in Johannesburg, South Africa (Abstract)
   

   J.B. Burnett-Zieman, T. Palanee-Philips, M. Plagianos, S. Mathur, S. Zulu, K. Reddy, I. Bruce, N. Ndlovu, L. Haddad, B. Friedland*
   

    

   TUPED341

   The impact of multilevel interventions on alcohol consumption, depression, stigma, and ART adherence among men living with HIV in India: Results from a 27-month longitudinal study (Abstract)
   

   T. Ha*, S. Schensul, R. Singh, L. Frank

3. Wednesday 07/24

   Workshop | 10:00–11:30 CEST | Room 14a/Channel 9

   WS07

   Two for the price of one: Simplifying access to HIV prevention and contraception with multipurpose prevention technologies (Abstract)
   

   Facilitators: Danielle Resar, Wawira Nyagah, Lori Miller, Barbara Friedland

    

   The dual prevention pill (DPP), which combines oral PrEP and oral contraception, could be the next multipurpose prevention technology (MPT) available, with expected approval in 2025. However, successful rollout of MPTs is highly dependent on integration of HIV and sexual and reproductive health (SRH) services and programmes, which has been challenging to realize. This workshop will leverage the expertise of HIV and SRH stakeholders to examine strategies for successfully introducing the DPP and use it as a model for delivering future MPTs. Discussions will focus on financing, regulatory, procurement and service delivery priorities for accelerating rollout and access to the DPP and other MPTs.

   Poster Exhibition | 12:00–13:00 CEST | Exhibition Hall

   (Posters are on display all day, but presenters stand by their posters during this time)

    

   WEPEC226

   Size matters: a randomized controlled trial to assess the impact of external diameter on preference, adherence, and acceptability of three intravaginal rings (IVRs) in 24 US couples (Abstract)
   

   B.A. Friedland*, M. Plagianos, I. Bruce, J. Sales, J. Atrio, A. Gottert, S. Shetty, C. Sant’Anna Marinho, J.B. Burnett-Zieman, R. Merkatz, L.B. Haddad

    

   WEPEC231

   The intravaginal ring acceptability scale (IVR-AS): A new tool to improve and standardize vaginal ring acceptability measurement among end-users (Abstract)
   

   A. Gottert*, B.A. Friedland, M. Plagianos, B. Zieman, J.M. Sales, J. Atrio, S. Shetty, C. Sant’Anna Marinho, R. Merkatz, L.B. Haddad

    

   WEPED428

   HIV-related discussions with sex partners by Nigerian transgender women and men who have sex with men (Abstract)
   

   A.B. Tiamiyu*, F. Hu, A. Kokogho, M.E. Charurat, C. Ekeh, S. Adebajo, E. Shoyemi, M. Iroezindu, J.A. Ake, S.D. Baral, R. Nowak, T.A. Crowell, TRUST/RV368 Study Group

   Symposium | 16:30–17:30 CEST | Room 1/Channel 2

   SY20

   The impact on access to HIV prevention and treatment services of migration and displacement among people in Southeast Asia (Abstract)
   

   Niranjan Saggurti (Speaker)

    

   Mobility and displacement are linked to reduced access to and poorer outcomes of HIV care due to several reasons. Mobile populations have unique vulnerabilities that may impact timeliness of clinic visits; location may also impact ability to access healthcare services. There may be specific challenges faced by some groups, including women and trans populations, in some parts of the world. This session will focus on the challenges to access to HIV prevention and care services introduced by migration, mobility and displacement across several locations and key populations globally.

4. Thursday 07/25

   Satellite | 07:00–08:00 CEST | Room 5/Channel 8

   

    

   SAT094

   HIV prevention for women: What’s in the current toolkit and where do we go from here? (Abstract)
   

   Co-organizers: Population Council and African Women Prevention Community Accountability Board

    

   The HIV epidemic is entering its fifth decade. Despite the availability of treatment and new prevention options, HIV/AIDS remains the leading cause of death in sub-Saharan Africa. To end this epidemic, women and girls need access to a variety of prevention products that align with their preferences. Currently available biomedical prevention options include oral PrEP, the monthly dapivirine vaginal ring (DVR or PrEP Ring) and the recently approved cabotegravir injectable (LA-CAB). Developers are working on expanding this toolkit with improvements on longer-acting injectables and rings as well as on-demand products such as inserts and multipurpose technologies including contraception. However, the promise of biomedical HIV prevention products will only be realized if women can obtain products easily and affordably and if they are empowered to use these products. Product choice empowers women to select and use products which fit their unique lifestyle and circumstances.

    

   IPM South Africa, an affiliate of the Population Council, and African Women’s HIV Prevention Accountability Board (AWPCAB) are co-hosting a panel of experts to discuss what is needed to make the current options available for all women and how to balance resources for expanding access to existing methods while simultaneously developing new methods. The expert panelists will discuss strategies for overcoming the barriers to expanding access to the existing methods, as well as the trade-offs investing in scaling up currently available methods versus developing new methods.

    

   Welcome and introductions
   Chilufya Kasanda, TALC, Zambia

    

   Panel discussion on HIV prevention in the time of choice
   Michelle Rodolph, WHO, Switzerland
   Sindy Matse, Ministry of Health, Eswatini
   Diantha Pillay, IPM an affiliate of the Population Council, South Africa
   Joyce Ng’ang’a, WACI Health, Kenya
   Patriciah Jeckonia, LVCT Health, Kenya
   Chilufya Kasanda, TALC, Zambia

    

   Closing remarks
   Chilufya Kasanda, TALC, Zambia

   Poster Exhibition | 12:00–13:00 CEST | Exhibition Hall

   (Posters are on display all day, but presenters stand by their posters during this time)

    

   THPEC203

   A dual prevention pill for HIV and pregnancy prevention: Results from a pilot study among Adolescent girls and young women in Zimbabwe (Abstract)

   B.A Friedland*, M. Plagianos, JB. Burnett-Zieman, S. Mathur, I. Bruce, A. Dandadzi, P. Musara, C. Murombedzi, L.B Haddad, N.M. Mgodi

    

   THPED425

   Stigma reduction and mental health promotion for sexual and gender minorities at risk of/living with HIV in Nigeria: implementation lessons (Abstract)

   A. Fernandez Eromhonsele, J. Pulerwitz, W. Tun, A. Gottert*, A. Adedimeji